DrugPatentWatch Database Preview
REOPRO Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for Tradename: REOPRO
| Patents: | 201 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for REOPRO |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for REOPRO |
Recent Clinical Trials for REOPRO
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Janssen Services, LLC | Phase 2 |
| St. Louis University | Phase 2 |
| SOS Attaque Cérébrale | Phase 4 |
Recent Litigation for REOPRO
Identify key patents and potential future biosimilar entrants
PTAB Litigation
| Petitioner | Date |
|---|---|
| Instrumentation Laboratory Company | 2019-04-24 |
| Instrumentation Laboratory Company | 2019-02-21 |
| Instrumentation Laboratory Company | 2017-11-30 |
Patent Text Search: US Patents for REOPRO
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Centocor Inc | REOPRO | abciximab | INJECTABLE; INJECTION | 103575 | 001 | 1994-12-22 | Start Trial | HemoSonics LLC (Charlottesville, VA) | 2031-02-15 | RX | search | |
| Centocor Inc | REOPRO | abciximab | INJECTABLE; INJECTION | 103575 | 001 | 1994-12-22 | Start Trial | INSPIREMD, LTD. (IL) | 2025-05-24 | RX | search | |
| Centocor Inc | REOPRO | abciximab | INJECTABLE; INJECTION | 103575 | 001 | 1994-12-22 | Start Trial | LOCAL PHARMA, INC. (Las Vegas, NV) | 2028-01-09 | RX | search | |
| Centocor Inc | REOPRO | abciximab | INJECTABLE; INJECTION | 103575 | 001 | 1994-12-22 | Start Trial | INSPIRE M.D. LTD (Tel Aviv, IL) | 2025-05-24 | RX | search | |
| Centocor Inc | REOPRO | abciximab | INJECTABLE; INJECTION | 103575 | 001 | 1994-12-22 | Start Trial | ALDERBIO HOLDINGS LLC (Las Vegas, NV) | 2028-11-25 | RX | search | |
| Centocor Inc | REOPRO | abciximab | INJECTABLE; INJECTION | 103575 | 001 | 1994-12-22 | Start Trial | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | search | |
| Centocor Inc | REOPRO | abciximab | INJECTABLE; INJECTION | 103575 | 001 | 1994-12-22 | Start Trial | Syntrix Biosystems, Inc. (Auburn, WA) | 2033-08-02 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for REOPRO
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 199901112 | Start Trial |
| Australia | 2019232879 | Start Trial |
| Spain | 2235291 | Start Trial |
| Germany | 69617070 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2008047367 | Start Trial |
| Germany | 60042785 | Start Trial |
| Japan | 2004526499 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
